Abstract

There is a huge interest in developing novel hollow fiber (HF) membranes able to modulate neural differentiation to produce in vitro blood–brain barrier (BBB) models for biomedical and pharmaceutical research, due to the low cell-inductive properties of the polymer HFs used in current BBB models. In this work, poly(ε-caprolactone) (PCL) and composite PCL/graphene (PCL/G) HF membranes were prepared by phase inversion and were characterized in terms of mechanical, electrical, morphological, chemical, and mass transport properties. The presence of graphene in PCL/G membranes enlarged the pore size and the water flux and presented significantly higher electrical conductivity than PCL HFs. A biocompatibility assay showed that PCL/G HFs significantly increased C6 cells adhesion and differentiation towards astrocytes, which may be attributed to their higher electrical conductivity in comparison to PCL HFs. On the other hand, PCL/G membranes produced a cytotoxic effect on the endothelial cell line HUVEC presumably related with a higher production of intracellular reactive oxygen species induced by the nanomaterial in this particular cell line. These results prove the potential of PCL HF membranes to grow endothelial cells and PCL/G HF membranes to differentiate astrocytes, the two characteristic cell types that could develop in vitro BBB models in future 3D co-culture systems.

Highlights

  • The application of membranes in the medical field has gained interest in the last few years and represents one of the most relevant markets for membranes

  • Our results suggest that the higher conductivity of PCL/G hollow fiber (HF) could promote the growth of cytoplasmatic extensions and serve as a guidance for C6 migration and differentiation

  • This work reports for the first time the fabrication of PCL/graphene hollow fibers by phase inversion to be used as tubular scaffolds for cell culture

Read more

Summary

Introduction

The application of membranes in the medical field has gained interest in the last few years and represents one of the most relevant markets for membranes. With the increasing concern of traumatic brain injuries, neurodegenerative diseases, and brain tumors, the progress of new therapies designed for central nervous system (CNS) illnesses is crucial for ensuring social and economic sustainability in an ageing world. In this line, tissue-engineered models could enable the study of clinically relevant processes such as CNS drug delivery efficiency through the blood–brain barrier (BBB) [4,5]. Our experimental study may contribute to the design of an in vitro BBB model for testing the permeability of innovative drugs for treating neurological disorders

Objectives
Methods
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.